This article was originally published here
Endocr Connect. 2021 March 1st: EC-20-0567.R2. doi: 10.1530 / EC-20-0567. Online before printing.
ABSTRACT
OBJECTIVE: COVID-19 in people...
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...